AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
THE MECHANISM OF BINDING OF LOW-MOLECULAR-WEIGHT ACTIVE-SITE INHIBITORS TO HUMAN ALPHA-THROMBIN
Authors: NILSSON T SJOLINGERICKSSON A DEINUM J
Citation: T. Nilsson et al., THE MECHANISM OF BINDING OF LOW-MOLECULAR-WEIGHT ACTIVE-SITE INHIBITORS TO HUMAN ALPHA-THROMBIN, Journal of enzyme inhibition, 13(1), 1998, pp. 11-29
INTERFERING WITH THE INHIBITORY MECHANISM OF SERPINS - CRYSTAL-STRUCTURE OF A COMPLEX FORMED BETWEEN CLEAVED PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 AND A REACTIVE-CENTER LOOP PEPTIDE
Authors: XUE YF BJORQUIST P INGHARDT T LINSCHOTEN M MUSIL D SJOLIN L DEINUM J
Citation: Yf. Xue et al., INTERFERING WITH THE INHIBITORY MECHANISM OF SERPINS - CRYSTAL-STRUCTURE OF A COMPLEX FORMED BETWEEN CLEAVED PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 AND A REACTIVE-CENTER LOOP PEPTIDE, Structure, 6(5), 1998, pp. 627-636
TRAUMATIC SCAPULAR AVULSION IN A CAT
Authors: GUERIN S DEINUM J DUGGAN P
Citation: S. Guerin et al., TRAUMATIC SCAPULAR AVULSION IN A CAT, Irish veterinary journal, 51(8), 1998, pp. 414-416
EFFECTS OF MELAGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR,ON THROMBIN AND FIBRINOLYTIC ENZYMES
Authors: GUSTAFSSON D ANTONSSON T BYLUND R ERIKSSON U GYZANDER E NILSSON I ELG M MATTSSON C DEINUM J PEHRSSON S KARLSSON O NILSSON A SORENSEN H
Citation: D. Gustafsson et al., EFFECTS OF MELAGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR,ON THROMBIN AND FIBRINOLYTIC ENZYMES, Thrombosis and haemostasis, 79(1), 1998, pp. 110-118
PLASMA-RENIN AND PRORENIN AND RENIN GENE VARIATION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS AND NEPHROPATHY
Authors: DEINUM J TARNOW L VANGOOL J DERKX F DEBRUIN R SCHALEKAMP M PARVING HH
Citation: J. Deinum et al., PLASMA-RENIN AND PRORENIN AND RENIN GENE VARIATION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS AND NEPHROPATHY, Journal of hypertension, 16, 1998, pp. 431-431
RELIABILITY OF A NOVEL IRMA OF RENIN FOR DIAGNOSIS OF LOW-RENIN STATES
Authors: DERKX FH DEINUM J DEBRUIN RJ VANGOOL JM SCHALEKAMP MA
Citation: Fh. Derkx et al., RELIABILITY OF A NOVEL IRMA OF RENIN FOR DIAGNOSIS OF LOW-RENIN STATES, Journal of hypertension, 16, 1998, pp. 1518-1518
MARKED ELEVATION OF ANGIOTENSIN-CONVERTING ENZYME IN HUMANS DOES NOT LEAD TO HIGH BLOOD-PRESSURE OR CARDIOVASCULAR-DISEASE
Authors: KRAMERS C BOORNSMA F DEINUM J ALHENCGELAS F LENDERS J DEKEIJZER M SWEEP C SMITS P
Citation: C. Kramers et al., MARKED ELEVATION OF ANGIOTENSIN-CONVERTING ENZYME IN HUMANS DOES NOT LEAD TO HIGH BLOOD-PRESSURE OR CARDIOVASCULAR-DISEASE, Journal of hypertension, 16, 1998, pp. 1529-1529
A DIRECT IMMUNORADIOMETRIC ASSAY OF HUMAN PRORENIN USING A PROSEGMENT-SPECIFIC ANTIBODY AND THE RENIN INHIBITOR REMIKIREN
Authors: DERKX FH MATHEWS S DEINUM J DEBRUIN RJ VANGOOL JM SCHALEKAMP MA
Citation: Fh. Derkx et al., A DIRECT IMMUNORADIOMETRIC ASSAY OF HUMAN PRORENIN USING A PROSEGMENT-SPECIFIC ANTIBODY AND THE RENIN INHIBITOR REMIKIREN, Journal of hypertension, 16, 1998, pp. 1538-1538
NO DIFFERENCE IN LOCAL ANGIOTENSIN I-TO-II CONVERSION IN SUBJECTS OF DIFFERENT ANGIOTENSIN-CONVERTING ENZYME GENOTYPES
Authors: OSTEROP APRM DEINUM J SCHALEKAMP MADH DANSER AHJ
Citation: Aprm. Osterop et al., NO DIFFERENCE IN LOCAL ANGIOTENSIN I-TO-II CONVERSION IN SUBJECTS OF DIFFERENT ANGIOTENSIN-CONVERTING ENZYME GENOTYPES, Hypertension, 32(4), 1998, pp. 8-8
PROBING EPITOPES ON HUMAN PRORENIN DURING ITS PROTEOLYTIC AND NONPROTEOLYTIC ACTIVATION
Authors: DEINUM J DERKX FHM SCHALEKAMP MADH
Citation: J. Deinum et al., PROBING EPITOPES ON HUMAN PRORENIN DURING ITS PROTEOLYTIC AND NONPROTEOLYTIC ACTIVATION, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1388(2), 1998, pp. 386-396
INCIDENCE OF POSTTRANSPLANT ERYTHROCYTOSIS (PTE) IN KIDNEY GRAFT RECIPIENTS WHERE THE RECIPIENT OF THE CONTRALATERAL KIDNEY DEVELOPED PTE
Authors: KLAASSEN RJL VANGELDER T DEMEESTER J DEINUM J WEIMAR W
Citation: Rjl. Klaassen et al., INCIDENCE OF POSTTRANSPLANT ERYTHROCYTOSIS (PTE) IN KIDNEY GRAFT RECIPIENTS WHERE THE RECIPIENT OF THE CONTRALATERAL KIDNEY DEVELOPED PTE, Transplantation, 65(8), 1998, pp. 1138-1139
IDENTIFICATION OF THE BINDING-SITE FOR A LOW-MOLECULAR-WEIGHT INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 BY SITE-DIRECTED MUTAGENESIS
Authors: BJORQUIST P EHNEBOM J INGHARDT T HANSSON L LINDBERG M LINSCHOTEN M STROMQVIST M DEINUM J
Citation: P. Bjorquist et al., IDENTIFICATION OF THE BINDING-SITE FOR A LOW-MOLECULAR-WEIGHT INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 BY SITE-DIRECTED MUTAGENESIS, Biochemistry, 37(5), 1998, pp. 1227-1234
SYNTHESIS AND BIOLOGICAL-ACTIVITY OF POTENT, LOW-MOLECULAR-WEIGHT RENIN INHIBITORS
Authors: SUEIRASDIAZ J JONES DM SZELKE M DEINUM J SVENSSON L WESTERLUND C SOHTELL M
Citation: J. Sueirasdiaz et al., SYNTHESIS AND BIOLOGICAL-ACTIVITY OF POTENT, LOW-MOLECULAR-WEIGHT RENIN INHIBITORS, The journal of peptide research, 50(4), 1997, pp. 248-261
DETERGENT TWEEN-80 MODIFIES THE SPECIFIC ACTIVITY OF PAI-1
Authors: EHNEBOM J BJORQUIST P ANDERSSON JO JOHANSSON T DEINUM J
Citation: J. Ehnebom et al., DETERGENT TWEEN-80 MODIFIES THE SPECIFIC ACTIVITY OF PAI-1, Fibrinolysis & proteolysis, 11(3), 1997, pp. 165-170
COMPARISON OF CHROMOGENIC SUBSTRATES FOR TISSUE-PLASMINOGEN ACTIVATORAND THE EFFECTS ON THE STABILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1
Authors: EHNEBOM J PUSA S BJORQUIST P DEINUM J
Citation: J. Ehnebom et al., COMPARISON OF CHROMOGENIC SUBSTRATES FOR TISSUE-PLASMINOGEN ACTIVATORAND THE EFFECTS ON THE STABILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1, FIBRINOLYSIS & PROTEOLYSIS, 11(5-6), 1997, pp. 287-293
THE IMPORTANCE OF ENZYME-INHIBITION KINETICS FOR THE EFFECT OF THROMBIN INHIBITORS IN A RAT MODEL OF ARTERIAL THROMBOSIS
Authors: ELG M GUSTAFSSON D DEINUM J
Citation: M. Elg et al., THE IMPORTANCE OF ENZYME-INHIBITION KINETICS FOR THE EFFECT OF THROMBIN INHIBITORS IN A RAT MODEL OF ARTERIAL THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 2026-2026
EFFECTS OF A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, MELAGATRAN,ON THROMBIN AND FIBRINOLYTIC ENZYMES - EVALUATION OF THE SUFFICIENT SELECTIVITY
Authors: GUSTAFSSON D ANTONSSON T BYLUND R ERIKSSON U GYZANDER E NILSSON I ELG M MATTSSON C DEINUM J PERSSON S KARLSSON O NILSSON A SORENSEN H
Citation: D. Gustafsson et al., EFFECTS OF A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, MELAGATRAN,ON THROMBIN AND FIBRINOLYTIC ENZYMES - EVALUATION OF THE SUFFICIENT SELECTIVITY, Thrombosis and haemostasis, 1997, pp. 2032-2032
THE IMPORTANCE OF ENZYME-INHIBITION KINETICS FOR THE EFFECT OF THROMBIN INHIBITORS IN A RAT MODEL OF ARTERIAL THROMBOSIS
Authors: ELG M GUSTAFSSON D DEINUM J
Citation: M. Elg et al., THE IMPORTANCE OF ENZYME-INHIBITION KINETICS FOR THE EFFECT OF THROMBIN INHIBITORS IN A RAT MODEL OF ARTERIAL THROMBOSIS, Thrombosis and haemostasis, 78(4), 1997, pp. 1286-1292
EPITOPES ON PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IMPORTANT FOR BINDING TO TISSUE-PLASMINOGEN ACTIVATOR
Authors: BJORQUIST P EHNEBOM J INGHARDT T DEINUM J
Citation: P. Bjorquist et al., EPITOPES ON PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IMPORTANT FOR BINDING TO TISSUE-PLASMINOGEN ACTIVATOR, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1341(1), 1997, pp. 87-98
LOSARTAN, AN ANGIOTENSIN-II (ANG-II) RECEPTOR ANTAGONIST, REDUCES HEMATOCRITS (HET) IN PATIENTS WITH POSTTRANSPLANT ERYTHROCYTOSIS (PTE)
Authors: KLAASSEN RJL VANGELDER T RISCHENVOS J DEINUM J TVELD AJMI WEIMAR W
Citation: Rjl. Klaassen et al., LOSARTAN, AN ANGIOTENSIN-II (ANG-II) RECEPTOR ANTAGONIST, REDUCES HEMATOCRITS (HET) IN PATIENTS WITH POSTTRANSPLANT ERYTHROCYTOSIS (PTE), Kidney international, 52(2), 1997, pp. 562-562
LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST REDUCES HEMATOCRITS IN KIDNEY-TRANSPLANT RECIPIENTS WITH POSTTRANSPLANT ERYTHROCYTOSIS
Authors: KLAASSEN RJL VANGELDER T RISCHENVOS J DEINUM J MANINTVELD AJ WEIMAR W
Citation: Rjl. Klaassen et al., LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST REDUCES HEMATOCRITS IN KIDNEY-TRANSPLANT RECIPIENTS WITH POSTTRANSPLANT ERYTHROCYTOSIS, Transplantation, 64(5), 1997, pp. 780-782
SERPIN CONFORMATIONAL CHANGE IN OVALBUMIN - ENHANCED REACTIVE CENTER LOOP INSERTION THROUGH HINGE REGION MUTATIONS
Authors: HUNTINGTON JA FAN BQ KARLSSON KE DEINUM J LAWRENCE DA GETTINS PGW
Citation: Ja. Huntington et al., SERPIN CONFORMATIONAL CHANGE IN OVALBUMIN - ENHANCED REACTIVE CENTER LOOP INSERTION THROUGH HINGE REGION MUTATIONS, Biochemistry, 36(18), 1997, pp. 5432-5440
CHARACTERIZATION OF THE COMPLEX OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY MASS-SPECTROMETRY AND SIZE-EXCLUSION CHROMATOGRAPHY
Authors: STROMQVIST M KARLSSON KE BJORQUIST P ANDERSSON JO BYSTROM M HANSSON L JOHANSSON T DEINUM J
Citation: M. Stromqvist et al., CHARACTERIZATION OF THE COMPLEX OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY MASS-SPECTROMETRY AND SIZE-EXCLUSION CHROMATOGRAPHY, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1295(1), 1996, pp. 103-109
CHARACTERIZATION OF NOVEL INDENOINDOLES .1. REDOX-RECYCLING WITH ASCORBATE
Authors: BJORQUIST P DEINUM J TAURE K WESTERLUND C OSTLUNDLINDQVIST AM
Citation: P. Bjorquist et al., CHARACTERIZATION OF NOVEL INDENOINDOLES .1. REDOX-RECYCLING WITH ASCORBATE, Biochemical pharmacology, 51(10), 1996, pp. 1403-1410
INFLUENCE OF THE DETERGENT TWEEN 80 ON THE ACTIVITY OF PAI-1 AND PROTECTION BY VITRONECTIN
Authors: BJORQUIST P EHNEBOM J KRISTIANSEN C DEINUM J
Citation: P. Bjorquist et al., INFLUENCE OF THE DETERGENT TWEEN 80 ON THE ACTIVITY OF PAI-1 AND PROTECTION BY VITRONECTIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1009-1009
Risultati: 1-25 | 26-35